|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
|
25373533 |
2015 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
|
24455489 |
2014 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group.
|
24996433 |
2014 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update.
|
23852704 |
2014 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Multitarget stool DNA testing for colorectal-cancer screening.
|
25006736 |
2014 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
|
23429431 |
2013 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
|
23263490 |
2013 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
|
22855150 |
2012 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
|
23012255 |
2012 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.
|
21917714 |
2011 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
|
17060676 |
2006 |
|
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.
|
12198537 |
2002 |
|
Colorectal Carcinoma
|
|
0.800 |
CausalMutation
|
CLINVAR |
|
|
|